FDA Adverse Event Injury Summary report: N

CENTURION VISION SYSTEM

MDR report key: 8647750 · Received May 28, 2019

Report

Report Number
2028159-2019-00945
Event Type
Injury
Date Received
May 28, 2019
Date of Event
April 30, 2019
Report Date
July 23, 2019
Manufacturer
ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
Product Code
HQC
PMA / PMN Number
K161794
Removal / Correction Number
NA
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THERE IS NO EVIDENCE CONTAINED WITHIN THE REPORTED INFORMATION AT THIS TIME THAT INDICATES THAT THE DESIGN OR PERFORMANCE OF THE SYSTEM HAD ANY EFFECT ON THE INTEGRITY OF THE POSTERIOR CAPSULE. THE COMPANY SERVICE REPRESENTATIVE EXAMINED THE SYSTEM AND COULD NOT DUPLICATE THE PROBLEM REPORTED. THE SYSTEM WAS THEN TESTED AND MET ALL PRODUCT SPECIFICATIONS. THE SYSTEM MANUFACTURING DEVICE HISTORY RECORD (DHR) WAS REVIEWED. BASED ON ASSESSMENT, THE PRODUCT MET SPECIFICATIONS AT THE TIME OF RELEASE. THE SYSTEM WAS FOUND TO MEET SPECIFICATIONS; THEREFORE, THE ROOT CAUSE OF THE REPORTED EVENT CANNOT BE DETERMINED CONCLUSIVELY. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Additional Manufacturer Narrative · 1

INVESTIGATION, INCLUDING ROOT CAUSE ANALYSIS, IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 1

A CUSTOMER REPORTED THAT DURING THE QUAD PHACOEMULSIFICATION PORTION OF A CATARACT PROCEDURE THE SYSTEM PRESSURE INCREASED AND THE PATIENT'S CAPSULE BROKE. THE WOUND WAS SUTURED. THE INTRAOCULAR LENS WAS NOT IMPLANTED. THE PATIENT WAS SENT FOR A RETINA EVALUATION. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
437937 CENTURION VISION SYSTEM UNIT, PHACOFRAGMENTATION HQC ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER NA NA

Patients

Seq Age Sex Outcome Treatment
1 Other